Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
Clinical trial NCT04398004 · COMPLETED
Trial details
- NCT number
- NCT04398004
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-06
- Primary completion
- 2020-11-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.